These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2445711)

  • 1. IgE-immunotoxins. I. IgE-intact ricin.
    Boltansky H; Dyer J; Esworthy S; Kaliner M
    Immunopharmacology; 1987 Sep; 14(1):35-45. PubMed ID: 2445711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgE-immunotoxins. II. IgE-ricin A-chain.
    Boltansky H; Slater J; Youle R; Isersky C; Kaliner M
    Immunopharmacology; 1987 Sep; 14(1):47-62. PubMed ID: 3500150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
    Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
    Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE immunotoxins. Effect of an IgE-ricin A chain conjugate on rat skin histamine content.
    Slater JE; Boltansky H; Kaliner M
    J Immunol; 1988 Feb; 140(3):807-11. PubMed ID: 2448377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
    Pietersz GA; Kanellos J; McKenzie IF
    Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human recombinant histamine releasing factor: functional evidence that it does not bind to the IgE molecule.
    Wantke F; MacGlashan DW; Langdon JM; MacDonald SM
    J Allergy Clin Immunol; 1999 Apr; 103(4):642-8. PubMed ID: 10200014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monoclonal antibodies produced by immunization with partially purified IgE receptor complexes.
    Stracke ML; Basciano LK; Fischler C; Berenstein EH; Siraganian RP
    Mol Immunol; 1987 Apr; 24(4):347-56. PubMed ID: 2443833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implanted IgE-Fc epsilon R complexes elicit IgE-mediated activation of RBL-2H cells.
    Ran S; Loyter A; Rivnay B
    Biochemistry; 1989 Jan; 28(2):644-51. PubMed ID: 2540803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of monoclonal antibodies with the IgE-receptor on rat mast cells and rat basophilic leukemia (RBL) cells.
    Micklefield G; König W; Pfeiffer P; Bohn A
    Agents Actions; 1986 Mar; 17(5-6):418-26. PubMed ID: 2422899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies specific to the alpha-subunit of the mast cell's Fc epsilon R block IgE binding and trigger histamine release.
    Baniyash M; Alkalay I; Eshhar Z
    J Immunol; 1987 May; 138(9):2999-3004. PubMed ID: 2437203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression and production of tumour necrosis factor by a rat basophilic leukaemia cell line (RBL-2H3) with IgE receptor triggering.
    Ohno I; Tanno Y; Yamauchi K; Takishima T
    Immunology; 1990 May; 70(1):88-93. PubMed ID: 2141321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of allergic reactions with monoclonal antibody to the high affinity IgE receptor.
    Kitani S; Kraft D; Fischler C; Mergenhagen SE; Siraganian RP
    J Immunol; 1988 Apr; 140(8):2585-8. PubMed ID: 2451693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein A vectorized toxins--I. Preparation and properties of protein A-ricin toxin conjugates.
    Ghetie MA; Laky M; Moraru I; Ghetie V
    Mol Immunol; 1986 Dec; 23(12):1373-9. PubMed ID: 3493427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-anti-IgE idiotypic antibodies mimic IgE in their binding to the Fc epsilon receptor.
    Baniyash M; Eshhar Z
    Eur J Immunol; 1987 Sep; 17(9):1337-42. PubMed ID: 2443366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged inhibition of IgE production in mice following treatment with an IgE-specific immunotoxin.
    Lustgarten J; Waks T; Eshhar Z
    Mol Immunol; 1996 Feb; 33(3):245-51. PubMed ID: 8649445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural cytotoxic (NC) cell activity in basophilic cells: release of NC-specific cytotoxic factor by IgE receptor triggering.
    Okuno T; Takagaki Y; Pluznik DH; Djeu JY
    J Immunol; 1986 Jun; 136(12):4652-8. PubMed ID: 2940298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simplified microassay for inhibition of protein synthesis in reticulocyte lysates by immunotoxins.
    Press OW; Vitetta ES; Martin PJ
    Immunol Lett; 1986 Nov; 14(1):37-41. PubMed ID: 3492442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a naphthalene derivative, TEI-6472, on histamine release and tyrosine phosphorylation in rat basophilic leukemia cells.
    Miyamoto H; Matsui K; Arai T
    Int J Immunopharmacol; 1995 May; 17(5):433-41. PubMed ID: 7591368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermia potentiates the activity of immunotoxin conjugates against common acute lymphoblastic leukaemia cells in vitro.
    Herrmann RP; Pelham JM; Raphael CL; Meyer BF; Davis RE
    Ann N Y Acad Sci; 1987; 511():428-35. PubMed ID: 2964219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors.
    White MV; Kaplan AP; Haak-Frendscho M; Kaliner M
    J Immunol; 1988 Nov; 141(10):3575-83. PubMed ID: 2460539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.